Cart
sales@molnova.com
RIPA-56
CAS No. 1956370-21-0
RIPA-56( RIPA56 | RIPA 56 )
Catalog No. M13064 CAS No. 1956370-21-0
A highly potent, selective, stable Receptor-interacting protein 1 (RIP1) inhibitor with IC50 of 13 nM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 29 | Get Quote |
|
| 10MG | 43 | Get Quote |
|
| 25MG | 77 | Get Quote |
|
| 50MG | 124 | Get Quote |
|
| 100MG | 203 | Get Quote |
|
| 200MG | 300 | Get Quote |
|
| 500MG | 503 | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameRIPA-56
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly potent, selective, stable Receptor-interacting protein 1 (RIP1) inhibitor with IC50 of 13 nM.
-
DescriptionA highly potent, selective, stable Receptor-interacting protein 1 (RIP1) inhibitor with IC50 of 13 nM; shows good selectivity in kinase panel screening, and does not IDO activity ( at >200 uM); efficiently protects mice from mTNFα-induced multi-organ damage.
-
In Vitro——
-
In Vivo——
-
SynonymsRIPA56 | RIPA 56
-
PathwayApoptosis
-
TargetRIP kinase
-
RecptorRIP kinase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1956370-21-0
-
Formula Weight221.29546
-
Molecular FormulaC13H19NO2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESCCC(C)(C)C(N(O)CC1=CC=CC=C1)=O
-
Chemical NameButanamide, N-hydroxy-2,2-dimethyl-N-(phenylmethyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Ren Y, et al. J Med Chem. 2017 Feb 9;60(3):972-986.
molnova catalog
related products
-
CSLP37
CSLP37 (RIPK2 inhibitor CSLP37) is a novel potent, ATP pocket-binding RIPK2 inhibitor with IC50 of 16.3 nM in ADPGlo assay.
-
RIPK1-IN-9
RIPK1-IN-9 is a potent and selective inhibitor of RIPK1, a dihydronaphthone compound, which inhibits U937 and L929 cells with an IC50 of 2 nM and 1.3 nM, respectively.
-
Necrostatin 2
Necrostatin 2 is a necrotic protein and receptor-interacting protein kinase 1 (RIPK1) inhibitor used to study inner ear disorders such as sudden deafness, dizziness and tinnitus.
